Tag: biotechnology
-
Small Business Grant Supports Bone Fracture Technology
An award from National Institutes of Health is funding development of a new injected drug that promises to repair bone fractures without surgery.
-
Gene-Edited Stem Cells Reduce Cocaine Seeking, Overdoses
The genome-editing technique Crispr used with stem cells is shown to release enzymes that reduce cocaine-seeking behavior in lab mice and protect against overdoses.
-
Trial Testing Universal Nasal Spray Flu Vaccine in Children
A clinical trial is underway evaluating a vaccine given as a nasal spray among children and teens that promises to protect against multiple flu types.
-
Gilead Gains Genome-Editing Hepatitis B Therapy
Biopharmaceutical company Gilead Sciences is acquiring a genome-editing technology for treating hepatitis-B, a viral disease affecting the liver.
-
Clinical Trial Testing Anti-Resistant Malaria Therapy
A clinical trial is getting underway that tests the safety and dosage levels of a new drug to treat malaria and block resistance from developing to it.
-
A.I. to Identify Treatment Drivers for Colorectal Cancer
A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer.
-
Clinical Trial Underway for Lassa Fever Treatment
An early-stage clinical trial is underway to test a treatment for Lassa fever, a viral disease found in West Africa, infecting as many as 300,000 individuals a year.
-
Genetic Engineering with Algae Boosts Crop Photosynthesis
Researchers developed a genetic engineering technique adding algae genes to some staple crops for capturing more carbon dioxide during photosynthesis and improving their yields.
-
Genentech Gains Modular Engineered Antibodies in $5B Deal
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers.
-
M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency
M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency.